Gambia vs Kyrgyzstan: Number of clinical trials
Gambia
3
in 2022
Kyrgyzstan
3
in 2023
Gambia rank
95th
Kyrgyzstan rank
95th
Number of clinical trials over time
- Gambia
- Kyrgyzstan
How they compare
Gambia currently reports 3 against 3 in Kyrgyzstan, a difference of 0.
The two have swapped places 6 times across 9 shared years of data; in 2013 it was Gambia ahead.
Gambia ranks 95th and Kyrgyzstan ranks 95th of 153 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Gambia | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.33 | 4 | 0.6667 | Kyrgyzstan |
| 2020s | 2 | 1.33 | 0.6667 | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Gambia or Kyrgyzstan?
- Gambia, at 3 against 3 in Kyrgyzstan as of 2022.
- What is the difference in number of clinical trials between Gambia and Kyrgyzstan?
- 0, with Gambia ahead.
- How many years of comparable data are there for Gambia and Kyrgyzstan?
- 9 years are reported by both, from 2013 to 2022.
- How do Gambia and Kyrgyzstan rank globally for number of clinical trials?
- Gambia ranks 95th and Kyrgyzstan ranks 95th of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.